European Psychiatry - Volume 33

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805

S445

Pitzer College, Psychology, Claremont-California, USA

Deparment of Mental Health, Juvenile Court Mental Health Service,

Monterey Park-California, USA

∗

Corresponding author.

Introduction

Telepsychiatry is increasingly utiilized to evaluate

and treat diagnostically and geographically diverse youth. (Szeftel

et al., 2012; Hilty et al., 2013). Important public health implications

arise for US psychiatrically ill youth, most of whomreceive no treat-

ment, others depend on pediatricians without input from a child

psychiatrist (Goldstein and Myers, 2014). Potential advantages of

telepsychiatry include increased access to care from child psychi-

atrists directly, and through collaborations with pediatricians, and

uniquely positive response in patients more communicative in this

setting (Pakyrek et al., 2010).

Objectives

– To present the effectiveness of Telepsychiatry in

psychiatrically ill youth, and specific subgroups who especially

benefit.

– To show increased access to psychiatric care occurs through col-

laborations between child psychiatrists and pediatricians.

Aims

To present the advantages of telepsychiatry for child and

adolescent mental health and clinicians.

Methods

Review of selected published Telepsychiatric evidence-

based research and best practice recommendations.

Results

– Psychiatrically ill youth are effectively evaluated and

treated using Telepsychiatry (Myers et al. (2011), Hilty et al., 2013).

– Very young children and youth with Autism SpectrumDisorders,

or anxiety disorders respond particularly positively to Telepsychi-

atry (Szeftel et al., 2012; Pakyuerek et al., 2010: Myers et al., 2010).

– Telepsychiatry provides increased access to care through collab-

orations between child psychiatrists and pediatricians (Goldstein

and Myers, 2014; Myers et al., 2011).

Conclusion

Telepsychiatry is a promising advantageous modality

for youth based on effectiveness, broad administration and unique

benefit for very young and socially impaired youth.

References not available.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1288

EV304

Management of psychiatric symptoms

in pediatric anti-NMDA receptor

encephalitis: Case report and

systematic review

S. Tang

∗

, O. Alpert

Children’s Hospital of Philadelphia, Child and Adolescent Psychiatry,

Philadelphia, USA

∗

Corresponding author.

Introduction

Anti-N-methyl-D-aspartate (NMDA) receptor

encephalitis is an autoimmune condition that causes serious psy-

chiatric symptoms. Nearly 40% of affected patients are pediatric in

age. Fewpublications detail management of psychiatric symptoms.

Objective

To guide clinical decision-making for psychiatrists

managing pediatric patients with anti-NMDA receptor encephali-

tis.

Aims

We present a systematic reviewof literature and an illustra-

tive case report of a 17-year-old girl who presented with psychosis,

agitation, and insomnia, and underwent treatment with olanzap-

ine, clonazepam, and clonidine.

Methods

PUBMED was searched for publications in English

describing anti-NMDA encephalitis (2007–November 2015). Pub-

lications were included if they met all of the following:

– novel data;

– reported treatment of psychiatric phenomena for patients aged

≤

18 years

– full text available. Thirty-four publications detailing 38 unique

cases were included.

Results

Psychiatric symptoms are summarized in

Table 1 ;

com-

mon treatment modalities are presented in

Table 2 .

The most

frequently used antipsychotics were risperidone (

= 16, 57%),

haloperidol (

= 10, 36%), and olanzapine (

= 10, 36%). Significant

adverse effects occurred, with neuroleptic malignant syndrome

diagnosed with high probability in 4 cases (13%), and suspected

in 5 cases (16%). Dystonia, rigidity, tremors, and bradykinesia were

also linked to medication side effects. All reported adverse events

coincided with antipsychotic administration.

Conclusions

Psychiatric symptoms in pediatric cases of anti-

NMDA receptor encephalitis were frequently managed with

antipsychotics and benzodiazepines. Though antipsychotics may

be necessary, serious side effects are concerning. Unlike in delir-

iumresulting fromother causes, benzodiazepines do not seemto be

contraindicated. ECT may also be of utility and was well-tolerated

in reported cases.

Table 1

Summary of psychiatric symptoms.

Table 2

Management of psychiatric symptoms.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1289

EV305

Feasibility of the stress and anger

management program on children

with high functioning autism

spectrum disorder in a sample

population from Karachi

B. Tauseef

∗

, Z. Z

adeh , B. Fatima

Bahria University, Institute of professional Psychology, Karachi,

Pakistan

∗

Corresponding author.

Introduction

Research shows that individuals with Autism Spec-

trum Disorder, struggle with emotional competence as compared

to their typically developing counterparts. This leads to internal-

izing (stress) and externalizing (anger management) problems in

the affected population. The stress and anger management pro-

gram (STAMP) designed by Scarpa et al. is a manualized treatment

protocol with good clinical efficacy.

Objective

The objective of the present study is to test the feasibil-

ity and suitability of STAMP as a systematized treatment protocol